Global Molecular Pharming Market 2025-2034 full Research Repot latest version is now available.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1712
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Molecular Pharming market are:
Rising Research in Bio-Farming
Growing Demand for Cost-Effective, Scalable, And Fast Methods Of Producing Vaccines And Therapeutic Proteins
Advantages Over traditional Methods of Protein Production
The following are the primary obstacles to the Molecular Pharming market’s expansion:
High Costs of Development and Scale-Up
Risks of Contamination
High Initial Investment Costs hamper Target Market Expansion
Future expansion opportunities for the global Molecular Pharming market include:
Rising Demand for Biologics
Rising Prevalence of Disease Indications
Expansion into Nutraceuticals to Fuel Focused Market Growth Opportunity
Key Industry Insights & Findings from the report:
North America is expected to have the largest market share in 2024 due to its sophisticated biopharmaceutical industry, significant R&D expenditures, and robust healthcare system, which allow for the regional commercialization of molecular pharmaceutics.
Maize, a grain used to create recombinant proteins such as antibodies, hormones, and vaccines, is expected to dominate the market in the next years.
Asia Pacific is expected to expand at the fastest rate due to significant success in applying modern agriculture methods.
The rising prevalence of chronic illnesses and the need for new therapies are boosting demand for biopharmaceuticals, which molecular pharming can effectively create.
Market Analysis:
Molecular pharming, also known as molecular farming, is a promising and cutting-edge branch of biotechnology that uses genetically engineered plants or animals to manufacture medications. This novel technique to drug manufacture, which utilizes natural biological processes within organisms to synthesize complex medicinal molecules, has the potential to be more cost efficient and scalable.
Scientists may insert particular genes into plants or animals through genetic engineering to create therapeutic proteins, biopharmaceuticals, and even vaccinations.
List of Prominent Players in the Molecular Pharming Market:
Leaf Expression Systems
ORF Genetics hf.
Agrenvec S.L.
PlantForm
Protalix Biotherapeutics
Kbio, Inc.
Cape Biologix Technologies (Cape Bio Pharm
Bright Biotech
Moolec Science SA
Miruku
Tiamat Sciences Corp.
IngredientWerks
Core Biogenesis
Diamante Società Benefit S.r.l.
Elo Life Systems
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02
Recent Developments:
In April 2024, Nobell Foods, a molecular farming firm that makes animal-free cheese with soy-derived casein proteins, rebranded as Alpine Bio and received a new dairy protein patent. The San Francisco-based firm will now function as a subsidiary under the new name, Alpine Bio, and its scope has been broadened to include 15 proteins that may be produced in diverse plants using molecular farming.
In October 2023, Moolec Science, which specializes in plant-based animal protein manufacturing via molecular pharming, raised $30 million from investors using convertible notes. The money will help the firm focus on expanding its research and development activities in more meat compounds and proteins. Moolec Science intends to include meat proteins into the matrix of soy and pea proteins, as opposed to standard ways of extracting and purifying animal proteins from their sources.
In September 2023, Bio Better, a Food Technology business, opened its first food-grade pilot plant in northern Israel to speed up the production of growth factors for meat production. Using tobacco plants as self-sustaining bioreactors, the business aims to produce 100kg per day and hopes to increase to 5 tons by 2025, lowering industry costs.
Molecular Pharming Market Dynamics:
Market Drivers: Rising Research in Bio-Farming
The expanding emphasis on bio pharming research is expected to drive up demand for molecular pharming in the pharmaceutical and biotechnology industries. Molecular pharming, also known as bio pharming, is the use of genetically altered plants or animals to manufacture therapeutic proteins, vaccines, and other biopharmaceuticals.
Ongoing research is helping to produce more efficient and accurate molecular pharming procedures. This includes advances in gene editing technologies such as CRISPR/Cas9, which allow scientists to precisely tweak host organisms for increased yields and product quality.
These advancements may lower production costs and make molecular pharming a more appealing choice for biopharmaceutical businesses. Researchers are looking at a larger variety of host species for molecular pharming, including as algae, fungus, and insects.
Challenges: High Costs of Development and Scale-Up
The high development and scale-up expenses impede molecular pharming’s growth and capacity to address expanding biopharmaceutical demands. Molecular pharming, a technological strategy that uses genetically engineered plants or animals to manufacture therapeutic proteins and medicines, has various benefits, including scalability, adaptability, and possible cost savings.
However, the early phases of development and subsequent scaling of manufacturing might be excessively costly.
North America Is Expected To Grow With the Highest CAGR During The Forecast Period
The North American area is expected to continue to dominate the worldwide molecular pharming industry. This is mostly due to the modern bio-pharmaceutical sector, which is distinguished by cutting-edge research and development projects.
The area is home to prominent companies that have made substantial contributions to the market’s growth. The increased frequency of chronic illnesses in North America, along with a growing desire for cost-effective medicines, is fueling the region’s molecular pharming industry.
Furthermore, the North American market benefits from a robust network of distribution channels and well-established supply chain management, allowing for effective and timely delivery of molecular pharming products to healthcare professionals and consumers. The region’s high healthcare spending and reimbursement regulations help to drive market expansion by ensuring that these modern medicines are accessible and affordable.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1712
Segmentation of Molecular Pharming Market-
By Technology-
Gene Gun
Agro infiltration
Electroporation
Agrobacterium-Mediated Gene Transfer
Others
By Application-
Recombinant Antibodies
Hormones
Vaccines
Industrial Enzymes
Proteins & Protein-Based Materials
Technical Reagents
Nutritional Products
Others
By Crop Source
Maize
Barley
Tobacco
Safflower
Rice
Alfalfa
By End-User
Biotechnology & Pharmaceutical Companies
Contract Manufacturing Organizations
Others
By Region-
North America-
The US
Canada
Mexico
Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
China
Japan
India
South Korea
South East Asia
Rest of Asia Pacific
Latin America-
Brazil
Argentina
Rest of Latin America
Middle East & Africa-
GCC Countries
South Africa
Rest of Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com